Search

MasaTHB
MasaTHB @MasaTHB ·
ギャルが遊びに来た午前。 掃除しまくってレコードなんか掛けてるいけてるさたでえ　甘い声大好きなんすよねぇ　タイの人も好きよねぇ #prep
24
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
SA approved a 2-monthly HIV prevention jab in 2022. It never reached public clinics. Now a better, cheaper jab is taking its place. Here's what happened to CAB-LA. #HIV #PrEP bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
107
HOPE worldwide Kenya
HOPE worldwide Kenya @HOPEwwKenya ·
Yesterday, HOPE worldwide Kenya joined Nakuru County & partners to celebrate the launch of long-acting injectable #PrEP: Lenacapavir (2× yearly) and Cabotegravir (every 2 months). A major step forward in expanding HIV prevention choices. #JipendeJiprep
1
27
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
Cabotegravir was the front end of our learning about long-acting injectables. It was an investment. It wasn't a waste. — Mitchell Warren, @HIVpxresearch. #HIV #PrEP #LEN #CAB-LA bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
49
Life4me+ по-русски
Life4me+ по-русски @life4meplus_ru ·
В проектах с контролируемым приемом препарата эффективность достигала 92%, а при сравнении форм лечения снижение риска варьировало от 66% до 89% между инъекционной и пероральной схемой. #PrEP #ВИЧ life4me.plus/ru/news/vich-1…
Эффективность доконтактной профилактики ВИЧ в различных группах риска: систематический обзор

Исследование показало, что снижение риска получения ВИЧ при PrEP колеблется от 49% до 86% в различных группах. Согласно результатам, среди участников, у которых зафиксировано регулярное применение...

From life4me.plus
20
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
CAB-LA: $180 per person per year. Generic lenacapavir: $40. That price gap kept a registered, effective medicine out of SA's publics. clinics — but it prepared the country for LEN’s roll-out. #HIV #PrEP bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
119
Bhekisisa
Bhekisisa @Bhekisisa_MG ·
SA approved a 2-monthly HIV prevention jab in 2022. It never reached public clinics. Now a better, cheaper jab is taking its place. Here's what happened to CAB-LA. #HIV #PrEP bhekisisa.org/article/2026-0…
CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives -...

CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit...

From bhekisisa.org
120
Shane Stout
Shane Stout @ShaneSDemoCrew ·
Probably the worst part about being on #prep has been the food lust…. They’re eating fries on tv right now and it’s killin me #alwayshungry
13
Revista Ícono Veracruz
Revista Ícono Veracruz @IconoVeracruz ·
🙋🏻��️ #Elección2026|| ¿Sabes para qué sirve el #PREP en una elección?, aquí te explica el Consejero Electoral del OPLE Veracruz, Mtro. Fernando García Ramos en qué consiste y para qué sirve, esto previo a la próxima elección que se llevará a cabo en el municipio de Tamiahuju5
1
26